Question 38

ISMP emphasized concentrated form: Insulin U-500

ISMP has highlighted the importance of concentrated forms in medication safety, particularly with insulin. Insulin U-500 is a concentrated form of insulin that is specifically noted for its risk of dosing errors if not handled correctly.

A) Insulin U-500

This option is correct as Insulin U-500 is a concentrated form of insulin that poses significant risks if not used properly. The ISMP has specifically emphasized the potential for errors associated with this concentration, making it a critical point of focus for healthcare providers.

B) Warfarin 5 mg

Warfarin is an anticoagulant medication that, while requiring careful management, does not fall under the category of concentrated forms. The standard dosing of Warfarin is not considered a concentrated form, hence it is not emphasized by ISMP in the same way as concentrated insulins.

C) Lidocaine 1%

Lidocaine 1% is a local anesthetic that does not represent a concentrated form in the context of the ISMP's emphasis on medication safety. This concentration is commonly used and does not carry the same risk of dosing errors associated with higher concentrations.

D) Midazolam 2 mg

Midazolam, while a potent medication, is not classified as a concentrated form in the same manner as Insulin U-500. The dosing of Midazolam is typically managed with caution, but it does not have the same emphasis from ISMP regarding concentration-related risks.

Conclusion

Insulin U-500 is the only option that represents a concentrated form highlighted by the ISMP, underscoring the importance of careful handling to prevent dosing errors. All other options, while important medications, do not carry the same concentrated risk and therefore do not align with ISMP's focus on safety in concentrated forms. This distinction makes Insulin U-500 the correct answer in this context.